• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cellectar Biosc (NQ: CLRB )

    2.190 +0.030 (+1.39%)
    Streaming Delayed Price Updated: 10:27 AM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cellectar Biosc

    < Previous 1 2 3 Next >
    Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
    Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
    Via Benzinga
    Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. 
    Via Benzinga
    Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million. 
    Via Benzinga
    Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
    Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for... 
    Via Benzinga
    Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
    Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
      
    Via Benzinga
    Recap: Cellectar Biosciences Q1 Earnings
    Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences... 
    Via Benzinga
    51 Biggest Movers From Thursday
    Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers 
    Via Benzinga
    Here's Why Cellectar Biosciences Shares Are Rising
    Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated... 
    Via Benzinga
    Recap: Cellectar Biosciences Q4 Earnings
    Cellectar Biosciences (NASDAQ:CLRB) reported its Q4 earnings results on Monday, March 21, 2022 at 08:30 AM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Enveric Biosciences (NASDAQ:ENVB)... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers PLx Pharma (NASDAQ:PLXP) stock in... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers Bellerophon Therapeutics (NASDAQ: 
    Via Benzinga
    Cellectar Bio's Iopofosine Data Shows Favorable Safety Profile In Head & Neck Cancer
    Cellectar Biosciences Inc (NASDAQ: CLRB) has completed part A portion of a safety and tolerability study of iopofosine I-131 (iopofosine) in combination with... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff... 
    Via Benzinga
    4 Penny Stocks Insiders Are Buying
    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Cellectar Biosciences (NASDAQ:CLRB 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers MorphoSys (NASDAQ:MOR) stock move... 
    Via Benzinga
    Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
    Cellectar Biosciences Inc (NASDAQ: CLRB) has received a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant of... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the biggest company by market cap to set a new 52-week low.... 
    Via Benzinga
    The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
    Via Benzinga
    Exposures Product Safety
    Cellectar, LegoChemBio Team Up To Develop Phospholipid Drug Conjugates For Solid Tumors
    Cellectar Biosciences Inc (NASDAQ: CLRB) has collaborated with LegoChemBio to develop and commercialize phospholipid drug conjugates (PDCs). Under the agreement,... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million... 
    Via Benzinga
    Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy
    Cellectar Biosciences Inc (NASDAQ: CLRB) announced updated data at the American Society of Clinical Oncology (ASCO) Annual Meeting from Phase 2 CLOVER-1 study of... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.